Crossmark

Metronomics: towards personalized chemotherapy?

Crossref DOI link: https://doi.org/10.1038/nrclinonc.2014.89

Published Online: 2014-06-10

Published Print: 2014-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

André, Nicolas

Carré, Manon

Pasquier, Eddy
License Information

Text and Data Mining valid from 2014-06-10
More Information

Article History

First Online: 10 June 2014

Competing interests

: N.A. declares he receives consulting honorarium from Sanofi. The other authors declare no competing interests.